Aspitrate 30 mg/150 mg Capsule
By Aspitrate
Rx
15 Capsule in a Strip

Composition
Isosorbide Mononitrate(30mg) + Aspirin(150mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
January, 2026

liver
Aspitrate 30 mg/150 mg Capsule is considered safe for use in individuals with liver disease, based on the limited available data. It appears that there may not be a requirement for adjusting the dosage of Aspitrate 30 mg/150 mg Capsule in such patients. However, it is advisable to seek guidance from your doctor before using this medication to ensure it is appropriate for your specific liver condition.

kidney
Aspitrate 30 mg/150 mg Capsule should be approached carefully if you have kidney problems. Adjusting the dose might be necessary, so seek advice from your doctor. Avoid using this capsule if you have severe kidney disease.

alcohol
When using Aspitrate 30 mg/150 mg Capsule, avoid alcohol to prevent symptoms like flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure.

driving
When taking Aspitrate 30 mg/150 mg Capsule, be cautious while driving as it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Aspitrate 30 mg/150 mg Capsule should not be used during pregnancy due to potential risks to the baby. In certain life-threatening cases, a doctor may prescribe it after considering the benefits and risks. Consult your doctor for guidance.

breastfeeding
Caution is advised when using Aspitrate 30 mg/150 mg Capsule while breastfeeding as it may pass into breastmilk and potentially harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹12.04
₹13.38
10.01% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025
